Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.

Dupilumab had previously been shown to be effective in the treatment of atopic dermatitis, but this research is the first to examine the drug's efficacy in children with atopic dermatitis and co ...

Results showed that dupilumab improved atopic dermatitis signs and symptoms in both groups of patients. "Many children suffer from multiple allergic conditions at the same time, so knowing that ...

Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...

Perioral dermatitis is a common inflammatory skin disease presenting as tiny papules or pustules localized around the mouth, nose, or eyes. It is often confused with acne vulgaris, rosacea ...

Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut ...

The Journal of Allergy and Clinical Immunology Source Reference: Tsai S, et al "Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic dermatitis: A population ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting ... across multiple indications, including atopic dermatitis (AD), in which it is considered the gold standard.

Getting approval in atopic dermatitis is viewed as a key step ... Regeneron's market-leading IL-4 and IL-13 antagonist Dupixent (dupilumab), which is also cleared for prurigo nodularis.